| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Organon & Co. | Director | Phantom Stock | 62,703 | $629,534 | $10.04 | 13 Jun 2025 | Direct |
| AMICUS THERAPEUTICS, INC. | Director | Common Stock | 31,115 | $384,647 | $12.36 | 10 Jun 2021 | Direct |
| AMICUS THERAPEUTICS, INC. | Director | Stock Options (right to buy) | 36,111 | 10 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OGN | Organon & Co. | 13 Jun 2025 | 1 | +$240,000 | 4 | Director | 16 Jun 2025, 17:19 |
| OGN | Organon & Co. | 07 Jun 2024 | 1 | +$200,000 | 4 | Director | 11 Jun 2024, 15:16 |
| OGN | Organon & Co. | 09 Jun 2023 | 1 | +$200,005 | 4 | Director | 13 Jun 2023, 16:48 |
| OGN | Organon & Co. | 10 Jun 2022 | 1 | +$199,994 | 4 | Director | 14 Jun 2022, 19:33 |
| FOLD | AMICUS THERAPEUTICS, INC. | 10 Jun 2021 | 2 | $0 | 4 | Director | 14 Jun 2021, 19:14 |
| OGN | Organon & Co. | 04 Jun 2021 | 1 | +$316,231 | 4 | Director | 08 Jun 2021, 20:36 |
| OGN | Organon & Co. | 02 Jun 2021 | 0 | $0 | 3 | Director | 02 Jun 2021, 17:54 |